For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Aggregate of All Three Arms. | All girls enrolled in the study 9-26 data were analyzed together as the original 72 subjects planned was not large enough to have statistically significant results once it became apparent that outcomes would need to be not only analyzed by subgroup but also by age 9-15 and 16-26. | 0 | None | 1 | 43 | 21 | 43 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| pregnancy | SYSTEMATIC_ASSESSMENT | Pregnancy, puerperium and perinatal conditions | NCI | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| bruise | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| shortness of breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| syncope vaso-vagal | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| dry socket following extraction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| otalgia | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Herpes zoster | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Injection site pain | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| insomnia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| musculoskeletal pain due to MVA injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| warts, plantar | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| upper respiratory infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Achiness | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| nausea or diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| lightheadedness | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| fever | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| strep throat | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| flare | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| thrush | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |